Evidence map›Paper›PMID 41268346›Full record

ArticleBioactive materials2025

Hydrogel scaffold encapsulating MSC-Exos and ZIF-8 promotes bone regeneration via coordinating osteogenesis and immunomodulation.

Yunhui Si, Xiaorong Li, Shuao Dong, Xueqin Gao, Yuetong Zhu, Linzhen Mo, Zhiwei Wang, Shuhan Wang, Chao Zhang

Abstract read
In one paragraph

Article in Bioactive materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yunhui SiSchool of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.
Xiaorong LiThe Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.
Shuao DongSchool of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.
Xueqin GaoSchool of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.
Yuetong ZhuThe Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.
Linzhen MoThe Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.
Zhiwei WangSouthern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Zhuhai, Guangdong, 519000, PR China.
Shuhan WangShenzhen Institute for Drug Control, Shenzhen Testing Center of Medical Devices, Shenzhen, Guangdong, 518057, PR China.
Chao ZhangSchool of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The limited bone regeneration and suboptimal immune responses constitute the major challenges in repairing critical-sized bone defects. As an emerging therapeutic modality, mesenchymal stem cell-derived exosomes (MSC-Exos) exhibit promising application prospects in bone regeneration. In this study, the bone-functionalized MSC-Exos are loaded into GelMA hydrogel scaffolds modified with the bone immunomodulator Zeolitic Imidazolate Framework-8 (ZIF-8) for the repair of critical-sized bone defects. The prepared MSC-Exos/ZIF-8@GelMA composite hydrogel demonstrates excellent biocompatibility and favors the adhesion and proliferation of bone marrow mesenchymal stem cells (BMSCs). The sustained release of exosomes and zinc ions endows the composite hydrogel with synergistically enhanced bone regeneration, angiogenesis, and immunomodulation. Specifically, the microRNA-23a-3p within internalized MSC-Exos activates the AKT signaling pathway in BMSCs by targeting the PTEN node and up-regulates the expression of osteogenesis-related markers. Meanwhile, it is demonstrated for the first time that ZIF-8 inhibits the activation of the non-classical NF-κB pathway in RAW264.7 cells under simulated inflammatory conditions, thereby downregulating pro-inflammatory cytokine expression and inducing M2-type polarization. The rat cranial bone defect model demonstrates that the composite hydrogel significantly enhances new bone formation and angiogenesis

Indexed as

HydrogelImmunomodulationMSC-ExosOsteogenesisZIF-8

Identifiers

PMID41268346
PMCPMC12628064

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.